| Next 10 |
Ad
ALDX Articles Aldeyra Therapeutics Inc.
home / stock / aldx / aldx articles
Articles | Aldeyra Therapeutics Inc. (NASDAQ:ALDX)
-
SAN DIEGO, June 13, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and s...
-
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern aroun...
-
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...
-
Gainers Cellectis S.A. (NASDAQ: CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with As...
-
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares are trading higher Wednesday after the company announced that it entered into an exclusive options...
-
PERCEPTIVE ADVISORS LLC, 10% Owner at Aldeyra Therapeutics (NASDAQ:ALDX), reported a large insider sell on October 18, according to a new SEC filin...
-
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% to 33,983.22 while the...
-
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,0...
-
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while...
Stock Information
Get ALDX Alerts
News, Short Squeeze, Breakout and More Instantly...
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
Ad
-
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administra...
-
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.21 for Q2 2024 Cano Health Inc. Class A (CANOQ) is expected to report for Q2 2024 Aytu BioPharma Inc. (AYTU) is expected to report for quarter end 2024-06-30 BlackBerry Limited (BB) is expected to report $-0.04 for Q2 2025 ...
-
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.21 for Q2 2024 FactSet Research Systems Inc. (FDS) is expected to report $3.6 for Q4 2024 China CITIC Bank Corp. Ltd. ADR (CHCJY) is expected to report for Q2 2024 Comera Life Sciences Holdings Inc. (CMRA) is expected to repor...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...